Nasdaq:US$15.81 (-0.23) | HKEX:HK$24.40 (-0.45) | AIM:£2.54 (-0.05)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate

1 items
a060704